1. Home
  2. IMVT vs YELP Comparison

IMVT vs YELP Comparison

Compare IMVT & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • YELP
  • Stock Information
  • Founded
  • IMVT 2018
  • YELP 2004
  • Country
  • IMVT United States
  • YELP United States
  • Employees
  • IMVT N/A
  • YELP N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • YELP Other Consumer Services
  • Sector
  • IMVT Health Care
  • YELP Consumer Discretionary
  • Exchange
  • IMVT Nasdaq
  • YELP Nasdaq
  • Market Cap
  • IMVT 2.8B
  • YELP 2.3B
  • IPO Year
  • IMVT N/A
  • YELP 2012
  • Fundamental
  • Price
  • IMVT $15.80
  • YELP $34.44
  • Analyst Decision
  • IMVT Buy
  • YELP Hold
  • Analyst Count
  • IMVT 10
  • YELP 6
  • Target Price
  • IMVT $40.14
  • YELP $34.00
  • AVG Volume (30 Days)
  • IMVT 1.3M
  • YELP 805.3K
  • Earning Date
  • IMVT 08-05-2025
  • YELP 08-07-2025
  • Dividend Yield
  • IMVT N/A
  • YELP N/A
  • EPS Growth
  • IMVT N/A
  • YELP 32.33
  • EPS
  • IMVT N/A
  • YELP 2.05
  • Revenue
  • IMVT N/A
  • YELP $1,437,846,000.00
  • Revenue This Year
  • IMVT N/A
  • YELP $6.65
  • Revenue Next Year
  • IMVT N/A
  • YELP $4.45
  • P/E Ratio
  • IMVT N/A
  • YELP $16.64
  • Revenue Growth
  • IMVT N/A
  • YELP 5.93
  • 52 Week Low
  • IMVT $12.72
  • YELP $32.29
  • 52 Week High
  • IMVT $34.47
  • YELP $41.72
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 53.39
  • YELP 32.43
  • Support Level
  • IMVT $15.11
  • YELP $35.26
  • Resistance Level
  • IMVT $17.08
  • YELP $35.89
  • Average True Range (ATR)
  • IMVT 0.76
  • YELP 0.81
  • MACD
  • IMVT -0.00
  • YELP -0.37
  • Stochastic Oscillator
  • IMVT 47.56
  • YELP 9.63

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

Share on Social Networks: